Nilgun Karali

Prof. Dr. Nilgun Karali


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
NKNilgun Karali
Nilgun Karali
AGAysel Gürsoy
Aysel Gürsoy
FKFatma Kandemirli
Fatma Kandemirli
NSNathaly Shvets
Nathaly Shvets
FKF. Betül Kaynak
F. Betül Kaynak
ADAnatholy Dimoglo
Anatholy Dimoglo

1 July 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
NKNilgun Karali
Nilgun Karali
AAAtilla Akdemir
Atilla Akdemir
FGFüsun Göktaş
Füsun Göktaş
PEPınar Eraslan Elma
Pınar Eraslan Elma
AAAndrea Angeli
Andrea Angeli
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 April 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AAAtilla Akdemir
Atilla Akdemir
ÖGÖzlen Güzel-Akdemir
Özlen Güzel-Akdemir
NKNilgun Karali
Nilgun Karali
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

6 September 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MCMerve Camci
Merve Camci
HŞHalil ŞENOL
Halil ŞENOL
AKAytekin Kose
Aytekin Kose
BMBerin Karaman Mayack
Berin Karaman Mayack
MAMuhammed Moyasar Alayoubi
Muhammed Moyasar Alayoubi
MGMikail Hakan Gezginci
Mikail Hakan Gezginci

2 May 2022 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PEPınar Eraslan‐Elma
Pınar Eraslan‐Elma
AAAtilla Akdemir
Atilla Akdemir
Emanuela BerrinoEmanuela Berrino
Emanuela Berrino
MBMurat BOZDAG
Murat BOZDAG
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
NKNilgun Karali
Nilgun Karali

10 November 2021 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
KDKübra Demir-Yazıcı
Kübra Demir-Yazıcı
ÇAÇağla Begüm Apaydın
Çağla Begüm Apaydın
ÖSÖzge Soylu-Eter
Özge Soylu-Eter
NÖNurten Özsoy
Nurten Özsoy
NKNilgun Karali
Nilgun Karali
Background: 2-Indolinone-based hydrazinecarbothioamides carrying a 3-phenylsulfonamide moiety (7–9) were designed by replacement of donepezil's pharmacophore group indanone with a 2-indolinone ring...